Introduction
Tetraspanins were discovered in the early 90s as proteins which span the membrane four times.
Today, the 33 known mammalian members of the tetraspanin family are involved in diverse biological processes including the regulation of immune responses, infection with pathogens and cancer progression [1] . As glycosylated and palmitoylated proteins, tetraspanins interact with each other and with many transmembrane proteins including integrins, cell adhesion proteins, growth factor and cytokine receptors and membrane embedded enzymes [2] [3] [4] [5] . Such an interaction network of tetraspanins and transmembrane proteins was previously referred to as the "tetraspanin web" [2] .
The transmembrane domains and the large extracellular loop of tetraspanins as well as the surrounding lipid composition contribute to these protein interactions. Most likely, different tetraspanins act in concert in a tissue-specific context in the regulation of the stability and intracellular trafficking of membrane proteins. This affects the steady state level and localization of tetraspanin partner proteins in a given cellular or membrane compartment [1] .
Members of the ADAM (A Disintegrin And Metalloproteinase) family which can mediate the proteolytic processing of membrane proteins referred to as ectodomain shedding [6] were also found to interact with certain tetraspanins. In particular, the interaction of tetraspanins with ADAM10 has raised attention due to its proteolytic function as an amyloid precursor protein (APP) -secretase, as the sheddase of the cellular prion protein (PrP c ) and as a Notch1 receptor site 2 proteinase [7] [8] [9] [10] was found to interact with members of the tetraspanin superfamily. A subfamily of tetraspanins, TspanC8, with eight cysteines in the large extracellular domain, appeared to have high affinity to ADAM10. Tspan5, 10, 14, 15, 17 and 33 interact with ADAM10 and regulate its exit from the ER and transport to the plasma membrane where ectodomain shedding occurs [11] [12] [13] [14] .
Overexpression or RNAi-mediated downregulation of the TspanC8s caused changes in the maturation process and stabilized the surface expression of ADAM10 [12] . The interaction between different TspanC8 proteins and ADAM10 starts in the ER [12] and mainly involves the large
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4 extracellular loop at the side of the TspanC8s and the membrane-proximal domain as well as the disintegrin domain in the ADAM10 protein [15] . The interaction of ADAM10 with different TspanC8s may differentially affect the shedding of ADAM10 substrates including Notch1 [16] . It is of note that the TspanC8 family was also recently implicated in a possible functional clustering of the -secretase complex and the APP -secretase, ADAM10 [17] .
Tetraspanin-3 (Tspan3) is another member of the tetraspanin superfamily but only contains six cysteines in the large luminal domain. It was shown to associate with claudin-11 and beta1 integrin thereby regulating the proliferation and migration of oligodendrocytes [18, 19] . Tspan3 is expressed in all stages in oligodendrocyte development but is most prominently expressed in neurons and astrocytes [19] . In brain, Tspan3 associates with the Nogo-A receptor sphingosine-1-phosphate receptor 2 (S1PR2). Tspan3 knockdown reduced the Nogo-A-induced S1PR2 clustering, cell spreading and the inhibition of neurite outgrowth [20] . In Xenopus leavis embryos Tspan3 is expressed in migratory neural crest cells [21] . Tspan3 was also found to be a causative factor in the development of acute myelogenous leukemia (AML) and deficiency of Tspan3 led to an impaired stem cell-renewal and disease propagation [22] .
Using a yeast split-ubiquitin based screening system we identified Tspan3 as a binding partner of ADAM10. This interaction did not affect the trafficking or maturation of the protease or its ability to cleave the neuronal cadherin (N-cadherin). However, cell-based experiments revealed that Tspan3 affected the stabilization of ADAM10 and APP at the cell surface. Our experiments suggest that Tspan3 is part of an interaction scaffold that associates with APP and -and -secretases at the plasma membrane and within the endocytic pathway.
6 incubation for 3-5 days at 30°C clones were selected and expanded. Prey plasmids were extracted and analyzed by sequencing (GATC).
Cell culture, transfection and plasmids
All cells were cultured in DMEM (Thermo Fisher Scientific, Waltham, USA) with 10% fetal calf serum (FCS) and 1% penicillin/streptomycin at 37°C, 5% CO 2 atmosphere and 95% relative humidity. HEK293 and N2A cells stably overexpressing APP695 or APP695swe (Swedish mutant provided by Michael Willem, DZNE, Munich) were additionally supplemented with 200 µg/ml of the antibiotic G418. HEK293 cells deficient for ADAM10 (A10-/-) or ADAM17 (A17-/-)were generated by using the CRISPR/Cas9 system. The cells were transiently transfected with Polyethylenimin Max (PEI, Polysciences, Hirschberg, Germany). For inhibition of ADAM10 cell culture medium was supplemented with 10 µM of the hydroxamate-based inhibitor GI254023X
(Iris Biotech, Marktredwitz, Germany) for 12 h. Mammalian expression vectors were pCI-neo (human APP695), pcDNA3.1Hygro (ADAM10) and pFrog3 (murine Tspan3-myc and Tspan15-myc) derived from pcDNA3 (Thermo Fisher Scientific, Waltham, USA) [25] . The myc-epitope was inserted after the last amino acid of Tspan3 or Tspan15, respectively. The myc-tagged murine Tspan7 expression plasmid was purchased from OriGene Technologies Rockville, USA (MR221859).
Generation of the Tspan3 Y243L mutant
Tspan3 Y243L was generated by mutating the cDNA sequence of myc-tagged wild type Tspan3.
cDNA sequence coding for the amino acid Tyrosine (Y) at position 243 was exchanged by the sequence coding for Leucine (L). Myc-tagged Tspan3 Y243L was again subcloned into the pFrog3
vector. The following primers were used: 
Peptide N-Glycosidase F (PNGase F) digestion
Mouse brain homogenates were prepared as described above. After homogenization, equal amounts of total protein were incubated for 5 min at 95°C with 5x denaturing buffer (250 mM Na 2 PO 4 , pH 8.0, 1% SDS, 4% β-mercaptoethanol). After denaturation 5x Triton solution (7.5% Triton X-100, 50 mM EDTA) and proteinase inhibitor cocktail were added. The samples were incubated with PNGase F (Roche, Diagnostics, Mannheim, Germany) or ddH 2 O for 2 h at 37°C and prepared for SDS-PAGE. 
SDS-PAGE and immunoblotting

Flow Cytometry
Cells were washed with cold PBS and incubated with 2 ml Accutase (PAA Laboratories, Dartmouth, USA) for 5 min at 37°C to detach cells from cell culture dishes. Cells were counted and RNA precursors were generated and microinjected into male nucleoli of zygotes isolated from C57BL/6N mice as described elsewhere [26] . Founder mice were genotyped for TALEN-mediated frameshift mutations. Resulting from this, mice with a 26 bp insertion mutation inducing a translational stop codon within exon2 of the Tspan3 gene were used for further breeding and analysis.
Generation of Tspan3 mutant mice
Animal experiments
All animal works were approved by the Animal welfare committee of the Christian AlbrechtsUniversity of Kiel (Germany) and were performed according to the guidelines of the Federation of European Laboratory Animal Science Associations (FELASA). 
Bioinformatics and Statistical analysis
Results
ADAM10-Tspan3 interaction in yeast and mammalian cells
We have previously identified Tspan15 as an ADAM10 interacting protein using a split-ubiquitin yeast screening assay [12] (Fig.1A(I) ). Applying the same approach using mouse brain cDNAs encoding for N-terminal tagged proteins as prey and mADAM10 as bait, we found Tspan3 as an
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13 additional ADAM10 interactor. Since yeast cells expressing both mouse ADAM10 and Tspan3 or Tspan15 as a positive control grew on tryptophan/leucine/histidine-deficient media plates we concluded a close proximity of bait and prey since only then ubiquitin was reconstituted and the histidine 3 gene was transcriptionally activated (Fig. 1A) . In contrast to Tspan15 belonging to a subfamily of tetraspanins characterized by the presence of eight cysteines (TspanC8) in their large extracellular loop Tspan3 is evolutionary and structurally different with only six cysteines (TspanC6) in the extracellular domain (Fig. 1B) . By analysing the expression of Tspan3 in different mouse tissues we found it most abundantly expressed in brain and intestine with hardly any expression in lung, liver and bone marrow (Fig. 1C) . Deglycosylation experiments revealed that
Tspan3 is glycosylated and the degree of glycosylation differs between different tissues (Fig. 1C,D) . Interestingly, by analysing post mortem human cortex samples (overview in Suppl. To also validate the interaction of Tspan3 and ADAM10 in mammalian cells we expressed a Cterminally myc-tagged mouse Tspan3 and wild type mouse ADAM10 in HeLa cells and coprecipitated both proteins with anti-myc and anti-ADAM10 antibodies, respectively (Fig. 1F ).
Tspan3 could be found in the precipitate after the pulldown of overexpressed and endogenous ADAM10 ( Fig. 1F(I) ). Vice versa, ADAM10 was found in the precipitate after Tspan3 pulldown ( Fig. 1F(II) ). As a positive control we included the co-expression of Tspan15 and ADAM10
revealing the established association [12] between both proteins (Fig.1F) . As negative controls immunoprecipitations of cells were included which were transfected with constructs expressing ADAM10 alone or the structurally related ADAM17 protease. We only found co-precipitation of Tspan3 with ADAM10 and not with ADAM17 (Suppl. Fig. S3 ). To also confirm the interaction between ADAM10 and Tspan3 at the endogenous level we used mouse brain homogenates from wild type and Tspan3 knockout mice and precipitated Tspan3 (Fig.1G) . We found Tpsan3 in the precipitates from wild type brain but not in the knockout precipitate nor in the antibody or bead control samples. Importantly, ADAM10 as well as full length APP (fl-APP) and the APP carboxyterminal fragment (APP-CTF) was only found in the precipitate from wild type brain. These experiments demonstrate that Tspan3 is an endogenous relevant interaction partner of ADAM10
and APP.
Our data suggest that Tspan3 is a tetraspanin member preferentially expressed in the central nervous system with an apparently higher expression in AD brains. Studies in yeast and mammalian cells suggest a specific interaction of Tspan3 with ADAM10 (-secretase) and APP. 
Tspan3 does not affect the maturation and surface expression of ADAM10 as compared to
Tspan15
To address the question of whether the interaction between ADAM10 and Tspan3 has a similar impact on the function of ADAM10 as described for Tspan15 which regulated the ER exit and the maturation of ADAM10 [12] we expressed C-terminally myc-tagged Tspan3 or Tspan15 in HeLa cells ( Fig. 2A(I) ) and in the murine neuroblastoma cell line N2A ( Fig. 2A,(II) ), respectively. As described previously, overexpression of Tspan15 led to an increase in the mature form of endogenous ADAM10 [12] . In contrast, despite its considerable overexpression, Tspan3 did not alter the ratio between the pro-and mature forms of the protease in both cell types ( Fig. 2A ). An interesting observation is that the carboxy-terminal fragments of ADAM10 (ADAM-CTFs of about 15 kDa), which are proposed to be generated by ADAM9 and ADAM15-mediated shedding followed by -secretase cleavage [28] or by autocatalysis [29] , were markedly increased upon Tspan3 expression in both cell types ( Fig. 2A) . Tspan3 overexpression in murine neuroblastoma N2A cells mainly increased the possible intracellular domain 15 kDa CTF of ADAM10 which is most likely a product of -secretase processing ( Fig. 2A,(II) ).
To analyse a possible change in the surface expression of ADAM10, we analyzed N2A cells using surface biotinylation (Fig. 2B(I) ) and fluorescence activated cell sorting (Fig. 2B(II) ). Tspan15 led to a considerable increase in the surface levels of ADAM10 but Tspan3 did not affect the amount of ADAM10 at the surface (Fig. 2B) . Taken together, our data suggests that Tspan3 modulates the ectodomain shedding and intramembrane proteolysis of ADAM10 without affecting the maturation of the protease and its delivery to the cell surface. Surface biotinylation and (C) fluorescence activated cell sorting (FACS) analysis confirmed a higher level of surface ADAM10 in N2A cells after expression of Tspan15 but not after Tspan3 expression. N2A cells were biotinylated after transfection with either an empty vector (mock), murine Tspan3-myc or Tspan15-myc. Following cell lysis total protein samples were taken and biotin-labeled proteins precipitated (pulldown). After immunoblotting Tspan3-myc, Tspan15-myc, ADAM10 and GAPDH as a negative control were detected. Abbreviations: Ab: antibody control; UT: untransfected. A one-way ANOVA statistical analysis followed by Bonferroni's multiple comparisons test was performed (*, p˂0,05, **, p˂0,01***, p˂0,001).
Tspan3 expression affects ADAM10-mediated APP carboxy-terminal C83 fragment generation
Although Tspan3 overexpression did not overtly affect the cellular localization of ADAM10, we also determined what effect it would have on ADAM10 activity. To do this we analyzed its impact on ADAM10-dependent generation of membrane-bound APP carboxy-terminal fragment (APP-CTF) as well as the generation of the CTF of the ADAM10 substrate, N-cadherin. Whereas Tspan3 expression led to a 2.9 fold increase in APP-CTF, it had no apparent effect on the generation of the N-cadherin-CTF (Fig. 3A, Suppl. Fig. S4 ). In contrast, Tspan15 overexpression increased Ncadherin cleavage (CTF-generation) while only mildly affecting the generation of APP-CTFs (Fig. 3A, Suppl. Fig. S4 ). Inhibition of ADAM10 after Tspan3 overexpression using a well described hydroxamate-based drug (GI254023X) [30] also reduced the level of the APP-CTFs to almost mock transfected levels confirming that the Tspan3 effect was to a large part mediated by ADAM10 (Fig. 3B) . Downregulation of the protease by ADAM10-specific siRNA in N2A cells led to a similar effect (i.e. a reduction of the Tspan-3-dependent appearance of APP-CTFs) (Fig. 3C) .
Also, in human embryonic kidney 293 (HEK) cells CRISPR/Cas9-mediated deletion of ADAM10
but not ADAM17 slightly reduced the appearance of the APP-CTF after Tspan3 expression (Fig. 3D ).
In agreement with the identified role of ADAM10 as the major APP -secretase [8, 9, 31] in HEK cells overexpressing the Swedish mutant of APP, overexpression of Tspan3 preferentially increased levels of the C83 APP fragment (-CTF, Fig. 3E ). Likewise, in murine N2A cells a gel system allowing a separation of the APP-derived CTFs revealed that Tspan3 mainly affected the production of the endogenous murine C83 species and not the C99 fragments of APP-CTFs and inhibition of -and -secretase did not alter the amount of this fragment (Suppl. Fig. S5 ).
Moreover, using HEK cells that stably expressed the Swedish mutant form of APP (K595N/M596L), we observed that Tspan3 significantly reduced the level of amyloid-protein (A) in the supernatant of these cells but only mildly altered the level of the soluble sAPP ectodomain (Fig. 3F) suggesting that in the mutant APP-swe expressing cells the generation of intracellular -CTF and extracellular sAPP follow different kinetics, or that their stability is differentially regulated by Tspan3. Alternatively, the -CTF may be generated by ADAM10-mediated trimming of the -CTF. 
Tspan3 is mainly localized in endocytic vesicles and interacts with the amyloid precursor protein and presenilin-1
To better understand the effect of Tspan3 on APP processing and CTF generation we first analyzed the subcellular localization of Tspan3 in HeLa cells. Myc-tagged Tspan3 showed a prominent colocalization with the early endosome protein EEA1 as well as the lysosomal membrane protein LIMP-2 ( Fig. 4A(I,II) ) with minor amounts at the plasma membrane. No apparent co-localization was observed with the protein disulfide-isomerase (PDI) as an endoplasmic reticulum (ER) marker ( Fig. 4A(III) ). Also at the endogenous level, Tspan3 co-localized in part with Rab5 and LAMP-2 ( Fig. 4A(IV,V) ) suggesting that the steady state distribution of Tspan3 is mainly in endosomes and lysosomes, respectively. Both endogenous but also overexpressed APP showed a prominent colocalization with myc-tagged Tspan3 in HeLa cells (Fig. 4B) suggesting that APP is part of a Tspan3 containing protein complex. Co-immunoprecipitation experiments in human APPexpressing HEK cells confirmed that both full length APP (fl-APP) and also APP-CTFs could be pulled down by precipitation of Tspan3 (Fig. 4C) . Interestingly, we also found the N-terminal fragment of presenilin-1 in the Tspan3 precipitate suggesting that Tspan3 provides an interaction platform for -and -secretases as well as for their common substrate APP (Fig. 4D) . Expression of Tspan3 but not Tspan15 in N2A cells caused a trend towards an increase in surface expression of
A C C E P T E D M A N U S C R I P T ACCEPTED MANUSCRIPT
23
full length APP and a significant increase in surface APP-CTF (Fig. 4E, Suppl. Fig. S6 ) as well as the presenilin-1-CTF (Suppl. Fig. S6 ) as revealed in a surface biotinylation experiment arguing for an APP and presenilin stabilizing role of Tspan3 at both the plasma membrane and possibly also within the endocytic pathway. (E) N2A cells were biotinylated after transfection with either the mock vector or murine Tspan3-myc or Tspan15-myc. Following cell lysis total protein samples were taken and after precipitation of biotin-labeled proteins immunoblotting of total lysates and bound fractions was performed. Tspan3-myc, and APP full length (fl) and APP carboxy-terminal fragments (APP-CTF) were detected. Quantification of the experiment (n=6) is provided below the blot. Statistical significance was determined using ANOVA ( **, p˂0,01).
A C C E P T E D M A N U S C R I P T
Mutation of a Tspan3 endocytosis motif causes decreased turnover of APP-CTFs
The increased levels of APP caused by the overexpression of Tspan3 prompted the question of whether modulating surface levels of Tspan3 would alter the expression of full length APP and APP-CTFs. We identified a "YELL" motif within the C-terminal cytoplasmic domain of Tspan3 (Fig. 5A ) which fits well with the common YXXΦ endocytosis motif, where Φ is a bulky hydrophobic amino acid [32] . Mutating the Tspan3 tyrosine residue 243 to alanine (Tspan3Y243A) resulted in a more prominent surface expression of Tspan3 and reduced co-localization with the early endosomal marker EEA1 in transfected HeLa cells (Fig. 5B) . Surface biotinylation in APPexpressing N2A cells confirmed the increased surface levels of the Tspan3Y243A mutant (Fig. 5C) which was accompanied by an increased surface expression of full length endogenous APP and APP-CTF (Fig. 5D ).
Our experiments point to a role of Tspan3 as an interaction scaffold for ADAM10. siRNA-mediated downregulation of endogenous Tspan3 in human neuroblastoma SH-SY5Y cells did not obviously affect the expression levels of APP, APP-CTFs and ADAM10 ( Fig. 5E(I) ). To evaluate if the absence of Tspan3 is compensated by other tetraspanins, the transcription level of TspanC6 
Tspan3-deficiency is most likely compensated in vivo
To address the in vivo role of Tspan3 we have generated Transcription activator-like effector but also an approximate 30-fold increase of Tspan5 (as a member of the TspanC8 family) (Fig. 6C ).
Other tetraspanins were only slightly (Cd63, Tspan12) or clearly (Tspan6) downregulated. The
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28 possible compensatory role of Tspan7 was validated by heterologous expression in N2A cells.
Similar to Tspan3 also Tspan7 led to a significant increase in the generation of APP-CTFs (Fig.   6D ).
Our in vivo data indicate that the lack of Tspan3 causes a complex adaptation of the expression of other tetraspanin family members which may contribute to an apparent normal function of ADAM10 and processing of its substrates despite a depletion of Tspan3. 
Discussion
The functional analysis of tetraspanins has been partially hampered by their redundant functions and their ability to form membrane-embedded protein domains which are able to interact with a number of membrane proteins. Such tetraspanin enriched microdomains [5] organize a spatial arrangement of membrane proteins thereby affecting biological processes like cell adhesion, signaling, endocytosis and proteolysis [5, 1, 33, 34] . The pathogenic relevance of APP proteolysis by the -and -secretases is also affected by tetraspanins [35, 36, 11, 14, 12, 37] . A recent study revealed that tetraspanins may physically associate with the -and -secretase complex in an active multiprotease complex at the plasma-membrane [17] . In agreement with this study we observed that Tspan3 interacts with both ADAM10 and presenilins. Importantly, it also assists to group APP as a substrate and the C-terminal cleavage product of APP in this complex. Our cell-based experiments reveal that Tspan3 is mainly found within the endocytic compartment and its endocytosis affects the cell surface expression and stability of its protein partners. We found Tspan3 to act in a different manner as the hitherto described tetraspanins belonging to the Tspan C8 family [35, 36, 11, 14, 12, 16] by not having an obvious impact on the maturation and intracellular transport of ADAM10 from the endoplasmic reticulum to the plasma membrane. Tspan3, a tetraspanin member with a pronounced expression in murine and human brain and in migratory neural crest cells [21] seems to excert stabilizing functions on ADAM10 and certain associated substrates (including APP and PrP c ) once they have reached the plasma membrane and become endocytosed. In this regard, it is of note that presenilins are partially found in late endosomes/lysosomes and they are involved in intracellular A production [38] . It is attractive to speculate that Tspan3 and other intracellular Tspans modulate the activity of intracellular amyloidogenesis. In how far Tspan3 also participates in the cell surface control and endocytosis of other cell surface molecules like claudin-11 and beta 1 integrin in oligodendrocytes or with the Nogo-A receptor S1PR2 in a similar manner [18] [19] [20] has not yet been addressed. Mechanisms of how exactly endocytosis of Tspan3 together with its bindings partners are controlled, remain to be determined. In case of the tetraspanin CD63, an association with adaptor protein complexes 2 and 3 was revealed leading to internalization of the H + ,K + -ATPase beta-subunit [39] . Our findings are in agreement with a role of certain tetraspanins in regulating the specific tetraspanin-interaction partner network by endocytosis.
Since Tspan3 was also found in lysosomes of cortical neurons and its overexpression increased levels of the APP-C83 fragment (-CTF) it might be speculated that its association with the full length form of APP and APP-CTFs after internalization has a protective effect preventing premature degradation of the proteins by lysosomal proteases [40] . It is known for some time that -and -secretase-derived APP-CTFs are found in late endocytic compartments [41] where A generation may also take place [42] . APP endocytosis and its potential control by Tspan3 may also affect A production as revealed by experiments where the cytosolic tail of APP was removed [43, 44] . The observation that Tspan3 expression is increased in AD brains may simply reflect an upregulation of the endocytic system in AD [45, 46] . However, elevated levels of Tspan3 may also directly contribute to C-terminal APP fragments and intracellular A production.
We could show that Tspan3 also physically interacts with ADAM10 and this binding directly well-known ADAM10 substrate [47] . This substrate specificity may be explained by specific interactions within the tetraspanin-enriched domains that allow more direct contact between the Tspan3/ADAM10 complex and APP as compared to N-cadherin.
Surprisingly, deficiency of Tspan3 in human neuroblastoma cells and in Tspan3 knockout mice neither directly affect the stability of ADAM10 nor the stability and proteolytic processing of APP.
A compensation by other members of the tetraspanin family seems likely and is supported by our observation that Tspan5 and Tspan7 are dramatically upregulated in the brains of the Tspan3 knockout mice. A lack of an upregulation in the neuroblastoma cell line SH-SY5Y suggest that the regulation of Tspan expression is cell-type specific. Tspan7 belongs to the TspanC6 subfamily and it is likely that similar to Tspan5,10,14,15,17 and 33 [11] [12] [13] [14] its increased expression could accelerate the plasma membrane delivery of ADAM10. A functional effect may therefore be masked by the redundant role and an efficient replacement of certain tetraspanins by others in order to ensure an efficient protein network. The lack of an overt phenotype in the Tspan3 knockout mice but also many other Tspan-deficient mice [33] supports such a view. Future Tspan knockout studies are required to better understand the ADAM10/Tspan interaction networks and their impact on the proteolysis of APP and other substrates. Such studies are also required to define Tspans as novel drug targets, allowing a more selective modulation of APP secretase activity which usually show a broad spectrum of substrates.
In conclusion, Tspan3 is revealed as a novel interactor of ADAM10 involved in its stabilization and that of the -secretase and APP. Due to its predominant localization in endosomes, it may exert major roles within the endocytic pathway, modulating the stability of proteolytic products of APP and contributing to intracellular A generation.
